Substance P enhances excitatory synaptic transmission on spinally projecting neurons in the rostral ventromedial medulla after inflammatory injury

Journal of Neurophysiology

Volumn 102, Issue 2, 2009, Pages 1139-1151

  Zhang, Liang ^a   Hammond, Donna L ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; FREUND ADJUVANT; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROKININ 1 RECEPTOR; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; INFLAMMATION; INJURY; MALE; MEDULLA OBLONGATA; NOCICEPTION; NONHUMAN; PAIN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

ANIMALS; BENZYLAMINES; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; ENZYME INHIBITORS; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUTAMIC ACID; INDOLES; INFLAMMATION; MALE; MALEIMIDES; MEDULLA OBLONGATA; NEURAL PATHWAYS; NEURONS; NEUROTRANSMITTER AGENTS; PAIN; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NEUROKININ-1; SEROTONIN; SUBSTANCE P; SULFONAMIDES; SYNAPTIC TRANSMISSION;

EID: 68149137426     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.91337.2008     Document Type: Article

References (79)

1. Afrah AW, Stiller CO, Olgart L, Brodin E, Gustafsson H. Involvement of spinal N-methyl-D-aspartate receptors in capsaicin-induced in vivo release of substance P in the rat dorsal horn. Neurosci Lett 316: 83-86, 2001.
2. Bird GC, Lash LL, Han JS, Zou X, Willis WD, Neugebauer V. Protein kinase A-dependent enhanced NMDA receptor function in pain-related synaptic plasticity in rat amygdala neurones. J Physiol 564: 907-921, 2005.
3. Brill J, Huguenard JR. Sequential changes in AMPA receptor targeting in the developing neocortical excitatory circuit. J Neurosci 28: 13918-13928, 2008.
4. 2+/calmodulin-dependent protein kinase isoforms in rat brain. J Neurosci 15: 6797-6808, 1995.
5. Budai D, Khasabov SG, Mantyh PW, Simone DA. NK-1 receptors modulate the excitability of ON cells in the rostral ventromedial medulla. J Neurophysiol 97: 1388-1395, 2007.
6. Burgess SE, Gardell LR, Ossipov MH, Malan TP, Jr, Vanderah TW, Lai J, Porreca F. Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain. J Neurosci 22: 5129-5136, 2002.
7. 2+/calmodulin- dependent protein kinase in developing rat brain. J Neurosci 10: 1788-1798, 1990.
8. Caberlotto L, Hurd YL, Murdock P, Wahlin JP, Melotto S, Corsi M, Carletti R. Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain. Eur J Neurosci 17: 1736-1746, 2003.
9. Carletti R, Corsi M, Melotto S, Caberlotto L. Down-regulation of amygdala preprotachykinin A mRNA but not 3H-SP receptor binding sites in subjects affected by mood disorders and schizophrenia. Eur J Neurosci 21: 1712-1718, 2005.
10. Cascieri MA, Ber E, Fong TM, Sadowski S, Bansal A, Swain C, Seward E, Frances B, Burns D, Strader CD. Characterization of the binding of a potent, selective, radioiodinated antagonist to the human neurokinin-1 receptor. Mol Pharmacol 42: 458-463, 1992.
11. Commons KG, Valentino RJ. Cellular basis for the effects of substance P in the periaqueductal gray and dorsal raphe nucleus. J Comp Neurol 447: 82-97, 2002.
12. Cumberbatch MJ, Chizh BA, Headley PM. Modulation of excitatory amino acid responses by tachykinins and selective tachykinin receptor agonists in the rat spinal cord. Br J Pharmacol 115: 1005-1012, 1995.
13. Derkach VA, Oh MC, Guire ES, Soderling TR. Regulatory mechanisms of AMPA receptors in synaptic plasticity. Nat Rev Neurosci 8: 101-113, 2007.
14. Diez-Guerra FJ, Veira JA, Augood S, Emson PC. Ontogeny of the novel tachykinins neurokinin A, neurokinin B and neuropeptide K in the rat central nervous system. Regul Pept 25: 87-97, 1989.
15. Dougherty PM, Palecek J, Zorn S, Willis WD. Combined application of excitatory amino acids and substance P produces long-lasting changes in responses of primate spinothalamic tract neurons. Brain Res Rev 18: 227-246, 1993.
16. 2+/calmodulin-dependent protein kinase in rat brain. J Neurosci 5: 3270-3277, 1985.
17. Fields H. State-dependent opioid control of pain. Nat Rev Neurosci 5: 565-575, 2004.
18. Fitzgerald M. Developmental biology of inflammatory pain. Br J Anaesth 75: 177-185, 1995.
19. Fitzgerald M, Koltzenburg M. The functional development of descending inhibitory pathways in the dorsolateral funiculus of the newborn rat spinal cord. Brain Res 389: 261-270, 1986.
20. Gao K, Mason P. Physiological and anatomic evidence for functional subclasses of serotonergic raphe magnus cells. J Comp Neurol 439: 426-439, 2001.
21. Gilbert M, Stelzner DJ. The development of descending and dorsal root connections in the lumbosacral spinal cord of the postnatal rat. J Comp Neurol 184: 821-838, 1979.
22. Guan Y, Guo W, Robbins MT, Dubner R, Ren K. Changes in AMPA receptor phosphorylation in the rostral ventromedial medulla after inflammatory hyperalgesia in rats. Neurosci Lett 366: 201-205, 2004.
23. Guan Y, Guo W, Zou SP, Dubner R, Ren K. Inflammation-induced upregulation of AMPA receptor subunit expression in brain stem pain modulatory circuitry. Pain 104: 401-413, 2003.
24. Guan Y, Terayama R, Dubner R, Ren K. Plasticity in excitatory amino acid receptor-mediated descending pain modulation after inflammation. J Pharmacol Exp Ther 300: 513-520, 2002.
25. Hamity M, White SR, and Hammond DL. Reversal of thermal hyperalgesia by microinjection of neurokinin-1 receptor (NK1) antagonist in the rostral ventromedial medulla (RVM): sustained pronociceptive effects of substance P (SP) in an inflammatory pain state. Soc Neurosci Abstr 72.7. 2008.
26. Hammond DL. Control systems for nociceptive afferent processing: the descending inhibitory pathways. In: Spinal Afferent Processing, edited by Yaksh TL. New York: Plenum, 1986, p. 363-390.
27. Han JS, Li W, Neugebauer V. Critical role of calcitonin gene-related peptide 1 receptors in the amygdala in synaptic plasticity and pain behavior. J Neurosci 25: 10717-10728, 2005.
28. 2+-permeable AMPA receptors underlies depolarization-induced long-term depression at mossy fiber CA3 pyramid synapses. J Neurosci 27: 11651-11662, 2007.
29. Hurley RW, Hammond DL. The analgesic effects of supraspinal mu and delta opioid receptor agonists are potentiated during persistent inflammation. J Neurosci 20: 1249-1259, 2000.
30. Hurley RW, Hammond DL. Contribution of endogenous enkephalins to the enhanced analgesic effects of supraspinal mu opioid receptor agonists after inflammatory injury. J Neurosci 21: 2536-2545, 2001.
31. Ikeda H, Heinke B, Ruscheweyh R, Sandkuhler J. Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia. Science 299: 1237-1240, 2003.
32. Ikeda H, Stark J, Fischer H, Wagner M, Drdla R, Jager T, Sandkuhler J. Synaptic amplifier of inflammatory pain in the spinal dorsal horn. Science 312: 1659-1662, 2006.
33. Ji RR, Befort K, Brenner GJ, Woolf CJ. ERK MAP kinase activation in superficial spinal cord neurons induces prodynorphin and NK-1 upregulation and contributes to persistent inflammatory pain hypersensitivity. J Neurosci 22: 478-485, 2002.
34. Ji RR, Kohno T, Moore KA, Woolf CJ. Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci 26: 696-705, 2003.
35. Keller BU, Konnerth A, Yaari Y. Patch clamp analysis of excitatory synaptic currents in granule cells of rat hippocampus. J Physiol 435: 275-293, 1991.
36. Khawaja AM, Rogers DF. Tachykinins: receptor to effector. Int J Biochem Cell Biol 28: 721-738, 1996.
37. Kincaid W, Neubert MJ, Xu M, Kim CJ, Heinricher MM. Role for medullary pain facilitating neurons in secondary thermal hyperalgesia. J Neurophysiol 95: 33-41, 2006.
38. Krause JE, Bu JY, Takeda Y, Blount P, Raddatz R, Sachais BS, Chou KB, Takeda J, McCarson K, DiMaggio D. Structure, expression and second messenger-mediated regulation of the human and rat substance P receptors and their genes. Reg Peptides 46: 59-66, 1993.
39. Lacoste B, Riad M, Descarries L. Immunocytochemical evidence for the existence of substance P receptor (NK1) in serotonin neurons of rat and mouse dorsal raphe nucleus. Eur J Neurosci 23: 2947-2958, 2006.
40. Li J, Baccei ML. Excitatory synapses in the rat superficial dorsal horn are strengthened following peripheral inflammation during early postnatal development. Pain 143: 56-64, 2009.
41. Liu H, Mantyh PW, Basbaum AI. NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature 386: 721-724, 1997.
42. Ljungdahl A, Hokfelt T, Nilsson G. Distribution of substance P-like immunoreactivity in the central nervous system of the rat. I. Cell bodies and nerve terminals. Neuroscience 3: 861-943, 1978.
43. Malcangio M, Fernandes K, Tomlinson DR. NMDA receptor activation modulates evoked release of substance P from rat spinal cord. Br J Pharmacol 125: 1625-1626, 1998.
44. Mantyh PW, Pinnock RD, Downes CP, Goedert M, Hunt SP. Correlation between inositol phospholipid hydrolysis and substance P receptors in rat CNS. Nature 309: 795-797, 1984.
45. Mantyh PW, Rogers SD, Honore P, Allen BJ, Ghilardi JR, Li J, Daughters RS, Lappi DA, Wiley RG, Simone DA. Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. Science 278: 275-279, 1997.
46. Marvizon JC, Martinez V, Grady EF, Bunnett NW, Mayer EA. Neurokinin 1 receptor internalization in spinal cord slices induced by dorsal root stimulation is mediated by NMDA receptors. J Neurosci 17: 8129-8136, 1997.
47. Mason P. Central mechanisms of pain modulation. Cur Opin Neurobiol 9: 436-441, 1999.
48. Miki K, Zhou QQ, Guo W, Guan Y, Terayama R, Dubner R, Ren K. Changes in gene expression and neuronal phenotype in brain stem pain modulatory circuitry after inflammation. J Neurophysiol 87: 750-760, 2002.
49. Mileusnic D, Lee JM, Magnuson DJ, Hejna MJ, Krause JE, Lorens JB, Lorens SA. Neurokinin-3 receptor distribution in rat and human brain: an immunohistochemical study. Neuroscience 89: 1269-1290, 1999.
50. Millan MJ. Descending control of pain. Prog Neurobiol 66: 355-474, 2002.
51. Nakaya Y, Kaneko T, Shigemoto R, Nakanishi S, Mizuno N. Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat. J Comp Neurol 347: 249-274, 1994.
52. Nazarian A, Gu G, Gracias NG, Wilkinson K, Hua XY, Vasko MR, Yaksh TL. Spinal N-methyl-D-aspartate receptors and nociception-evoked release of primary afferent substance P. Neuroscience 152: 119-127, 2008.
53. Pacharinsak C, Khasabov SG, Beitz AJ, Simone DA. NK-1 receptors in the rostral ventromedial medulla contribute to hyperalgesia produced by intraplantar injection of capsaicin. Pain 139: 34-46, 2008.
54. Pellegrini-Giampietro DE, Bennett MV, Zukin RS. Differential expression of three glutamate receptor genes in developing rat brain: an in situ hybridization study. Proc Natl Acad Sci USA 88: 4157-4161, 1991.
55. Pellegrini-Giampietro DE, Bennett MV, Zukin RS. Are Ca(2+)-permeable kainate/AMPA receptors more abundant in immature brain? Neurosci Lett 144: 65-69, 1992.
56. Pinto M, Sousa M, Lima D, and Tavares I. Participation of mu-opioid, GABA(B), and NK1 receptors of major pain control medullary areas in pathways targeting the rat spinal cord: implications for descending modulation of nociceptive transmission. J Comp Neurol 510: 175-187, 2008.
57. Pomeroy SL, Behbehani MM. Response of nucleus raphe magnus neurons to iontophoretically applied substance P in rats. Brain Res 202: 464-468, 1980.
58. Porreca F, Ossipov MH, Gebhart GF. Chronic pain and medullary descending facilitation. Trends Neurosci 25: 319-325, 2002.
59. Quirion R, Dam TV. Ontogeny of substance P receptor binding sites in rat brain. J Neurosci 6: 2187-2199, 1986.
60. Randic M, Jiang MC, Cerne R. Long-term potentiation and long-term depression of primary afferent neurotransmission in the rat spinal cord. J Neurosci 13: 5228-5241, 1993a.
61. Randic M, Jiang MC, Rusin KI, Cerne R, Kolaj M. Interactions between excitatory amino acids and tachykinins and long-term changes of synaptic responses in the rat spinal dorsal horn. Regul Pept 46: 418-420, 1993b.
62. Rusin KI, Bleakman D, Chard PS, Randic M, Miller RJ. Tachykinins potentiate N-methyl-D-aspartate responses in acutely isolated neurons from the dorsal horn. J Neurochem 60: 952-960, 1993a.
63. Rusin KI, Jiang MC, Cerne R, Randic M. Interactions between excitatory amino acids and tachykinins in the rat spinal dorsal horn. Brain Res Bull 30: 329-338, 1993b.
64. Rusin KI, Ryu PD, Randic M. Modulation of excitatory amino acid responses in rat dorsal horn neurons by tachykinins. J Neurophysiol 68: 265-286, 1992.
65. Saffroy M, Torrens Y, Glowinski J, Beaujouan JC. Autoradiographic distribution of tachykinin NK2 binding sites in the rat brain: comparison with NK1 and NK3 binding sites. Neuroscience 116: 761-773, 2003.
66. Sahyoun N, LeVine H, 3rd, Burgess SK, Blanchard S, Chang KJ, Cuatrecasas P. Early postnatal development of calmodulin-dependent protein kinase II in rat brain. Biochem Biophys Res Commun 132: 878-884, 1985.
67. Sandkuhler J. Understanding LTP in pain pathways. Mol Pain 3: 9, 2007.
68. Soderling TR, Derkach VA. Postsynaptic protein phosphorylation and LTP. Trends Neurosci 23: 75-80, 2000.
69. 2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells. Biochem Biophys Res Commun 181: 968-975, 1991.
70. Sykes KT, White SR, Hurley RW, Mizoguchi H, Tseng LF, Hammond DL. Mechanisms responsible for the enhanced antinociceptive effects of microopioid receptor agonists in the rostral ventromedial medulla of male rats with persistent inflammatory pain. J Pharmacol Exp Ther 322: 813-821, 2007.
71. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, and et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266: 15771-15781, 1991.
72. Urban MO, Gebhart GF. Central mechanisms in pain. Med Clin North Am 83: 585-596, 1999.
73. Vanegas H, Schaible HG. Descending control of persistent pain: inhibitory or facilitatory? Brain Res Brain Res Rev 46: 295-309, 2004.
74. Woolf CJ, Costigan M. Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proc Natl Acad Sci USA 96: 7723-7730, 1999.
75. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 288: 1765-1769, 2000.
76. Xu M, Kim CJ, Neubert MJ, Heinricher MM. NMDA receptor-mediated activation of medullary pro-nociceptive neurons is required for secondary thermal hyperalgesia. Pain 127: 253-262, 2007.
77. Yasuda H, Barth AL, Stellwagen D, Malenka RC. A developmental switch in the signaling cascades for LTP induction. Nat Neurosci 6: 15-16, 2003.
78. Zeng J, Thomson LM, Aicher SA, Terman GW. Primary afferent NMDA receptors increase dorsal horn excitation and mediate opiate tolerance in neonatal rats. J Neurosci 26: 12033-12042, 2006.
79. Zhang L, Sykes KT, Buhler AV, Hammond DL. Electrophysiological heterogeneity of spinally projecting serotonergic and nonserotonergic neurons in the rostral ventromedial medulla. J Neurophysiol 95: 1853-1863, 2006.